Stefanos Kalomoiris
Stefanos Kalomoiris
Stem Cell Program, UC Davis
Verified email at
Cited by
Cited by
Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo
J Beegle, K Lakatos, S Kalomoiris, H Stewart, RR Isseroff, JA Nolta, ...
Stem cells 33 (6), 1818-1828, 2015
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors
T Meyerrose, S Olson, S Pontow, S Kalomoiris, Y Jung, G Annett, G Bauer, ...
Advanced drug delivery reviews 62 (12), 1167-1174, 2010
Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy
FA Fierro, S Kalomoiris, CS Sondergaard, JA Nolta
Stem cells 29 (11), 1727-1737, 2011
Concise review: MicroRNA function in multipotent mesenchymal stromal cells
EA Clark, S Kalomoiris, JA Nolta, FA Fierro
Stem cells 32 (5), 1074-1082, 2014
Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington's disease mouse models
K Pollock, H Dahlenburg, H Nelson, KD Fink, W Cary, K Hendrix, G Annett, ...
Molecular therapy 24 (5), 965-977, 2016
Characterization and In Vivo Testing of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells
W Gruenloh, A Kambal, C Sondergaard, J McGee, C Nacey, S Kalomoiris, ...
Tissue engineering Part A 17 (11-12), 1517-1525, 2011
Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin
SD Olson, A Kambal, K Pollock, GM Mitchell, H Stewart, S Kalomoiris, ...
Molecular and Cellular Neuroscience 49 (3), 271-281, 2012
Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell–derived induced pluripotent stem cells
A Kambal, G Mitchell, W Cary, W Gruenloh, Y Jung, S Kalomoiris, ...
Molecular Therapy 19 (3), 584-593, 2011
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
JR Beegle, NL Magner, S Kalomoiris, A Harding, P Zhou, C Nacey, ...
Molecular Therapy-Methods & Clinical Development 3, 16053, 2016
Allele-specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human huntington's disease fibroblasts
KD Fink, P Deng, J Gutierrez, JS Anderson, A Torrest, A Komarla, ...
Cell transplantation 25 (4), 677-686, 2016
FGF2 induces migration of human bone marrow stromal cells by increasing core fucosylations on N-glycans of integrins
B Awan, D Turkov, C Schumacher, A Jacobo, A McEnerney, A Ramsey, ...
Stem cell reports 11 (2), 325-333, 2018
Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow‐Derived Mesenchymal Stem Cells
S Kalomoiris, AC Cicchetto, K Lakatos, JA Nolta, FA Fierro
Journal of cellular biochemistry 117 (9), 2128-2137, 2016
Mesenchymal stem cells respond to hypoxia by increasing diacylglycerols
K Lakatos, S Kalomoiris, B Merkely, JA Nolta, FA Fierro
Journal of cellular biochemistry 117 (2), 300-307, 2016
CD25 preselective anti-HIV vectors for improved HIV gene therapy
S Kalomoiris, JT Lawson, RX Chen, G Bauer, JA Nolta, JS Anderson
Human gene therapy methods 23 (6), 366-375, 2012
Genetic monitoring and effects of stocking practices on small Cyprinus carpio populations
N Karaiskou, M Lappa, S Kalomoiris, G Oikonomidis, C Psaltopoulou, ...
Conservation genetics 12 (5), 1299-1311, 2011
Mesenchymal stem cells as a delivery vehicle for intercellular delivery of RNAi to treat Huntington's disease
GA Mitchell, SD Olson, KM Pollock, A Kambal, WA Cary, K Pepper, ...
NEUROLOGY 76 (9), A541-A541, 2011
Huntington's Disease Mouse Models
K Pollock, H Dahlenburg, H Nelson, KD Fink, W Cary, K Hendrix, G Annett, ...
Molecular Therapy 24 (5), 965-977, 2016
Mesenchymal stem cells engineered to overexpress brain-derived neurotrophic factor as a proposed therapeutic for Huntington’s disease (S25. 007)
V Wheelock, K Pollock, H Dahlenberg, H Nelson, K Fink, W Cary, ...
Neurology 86 (16 Supplement), 2016
Human Mesenchymal Stem Cells Genetically Engineered to Produce Brain-derived Neurotrophic Factor Improve Outcomes in Huntington' s disease Models
K Pollock, H Dahlenburg, H Nelson, KD Fink, W Cary, K Hendrix, G Annett, ...
Role of MiRNAs and HMGA2 in Human Mesenchymal Stem Cells
S Kalomoiris
University of California, Davis, 2016
The system can't perform the operation now. Try again later.
Articles 1–20